HOME >> MEDICINE >> NEWS
Combination vaccine produces lower immune response than vaccines administered separately

A combination vaccine developed to reduce the number of vaccines infants receive appears to provide less immunity than the vaccines administered individually, according to a study in the April 13 issue of JAMA.

The development of immunogenic vaccines against major diseases of childhood has dramatically decreased the rates of invasive disease, according to background information in the article. Since the introduction of a monovalent serogroup C meningococcal glycoconjugate vaccine (MenC) into the United Kingdom routine immunization schedule in November 1999, group C meningococcal disease has decreased by 87 percent in the ages targeted for vaccination, with estimated vaccine efficacy of 90 percent. Within 2 years of the introduction of a 7-valent pneumococcal glycoconjugate vaccine into the recommended infant schedule in the United States, there was a 69 percent reduction in culture-positive invasive pneumococcal disease in children younger than 2 years.

The advent of these efficacious and safe vaccines has increased pressure on crowded infant immunization schedules. Infants in the United States receive up to 20 separate vaccine injections over 5 immunization encounters at ages 2, 4, 6, 12, and 18 months to protect against disease due to hepatitis B, diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, varicella, H influenzae type b, and pneumococcus. The inclusion of MenC would add a further 3 to 4 doses to the U.S. regimen. The development of combination vaccines has become a priority. The combining of pneumococcal and meningococcal conjugate vaccines has the potential to spare U.S. infants up to 4 extra injections by age 18 months and to decrease parental and clinician concerns about the number of vaccinations in early childhood.

Jim P. Buttery, F.R.A.C.P., formerly of the University of Oxford, Churchill Hospital, Headington, Oxford, U.K., and colleagues conducted a study to determine the immunogenicity and safety of a combinati
'"/>

Contact: Jim P. Buttery, F.R.A.C.P.
jim.buttery@rch.org.au
JAMA and Archives Journals
12-Apr-2005


Page: 1 2

Related medicine news :

1. Combination treatment stymies breast cancer growth
2. Combination therapy spares some head and neck patients from surgery
3. Combination of personality traits increases risk for heart disease
4. Combination therapy may improve survival for pancreatic cancer
5. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
6. Combination of three new, high-powered MRI systems at PENN is a first in the US
7. Dynamic duo: Combination therapy reverses type 1 diabetes
8. Combination of interventions can substantially reduce incidence of malaria in people with HIV
9. Combination therapy improves AIDS-related lymphoma outcome
10. Combination treatment for brain cancer not detrimental to patients quality of life
11. Combination microbicides protect monkeys against HIV-like virus

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... , ... Grass pollen is the main cause of hay fever in the United States, with ... pollen runs from May to July each year; with the worst time for sufferers being ... barrier balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they are proven ...
(Date:3/29/2017)... ... , ... Sports Brand EXOUS Bodygear announced today a special sale price for ... remaining days of March, the price will be only $19.97. The EXOUS Bodygear 65cm ... $10 (regular retail price $19.97). , The special promotional prices are to help individuals ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based on research ... challenges employers face in trying to balance both short-term and long-term benefits demands. ... Adding to the growing complexity, companies are finding that the short-term strategies used ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... (MOBs) and other outpatient facilities, and who are the most active developers? ... questions, Revista and Healthcare Real Estate Insights (HREI) found that outpatient medical real ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an important webinar — Home ... PM ET. A recording of the webinar will also be made available following its ... and hospice companies are still popular targets for healthcare investors. This highly fragmented sector ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017  Bodycad announced today that it ... 510(k) clearance for its Bodycad Unicompartmental Knee System, ... orthopaedic restoration. Bodycad is the first Canadian company ... implant system. Bodycad,s revolutionary Unicompartmental ... of the patient,s unique anatomical features and kinematics. ...
(Date:3/29/2017)... Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer ... N. Stengone , president and chief executive officer, will present an ... Annual Healthcare Conference on Wednesday, April 5, 2017, at 11:20 ... in New York City . About ... Avelas ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... to their offering. ... The global orthopedic navigation system market is ... population prone to orthopedic diseases is a key contributing factor ... period. Osteoarthritis and osteoporosis are most common disorders in the ...
Breaking Medicine Technology:
Cached News: